Provided by Tiger Trade Technology Pte. Ltd.

ARS PHARMACEUTICALS INC

4.15
-0.0150-0.36%
Post-market: 4.10-0.0500-1.20%19:40 EDT
Volume:1.87M
Turnover:7.79M
Market Cap:412.71M
PE:-1.91
High:4.30
Open:4.26
Low:4.12
Close:4.17
52wk High:13.15
52wk Low:4.12
Shares:99.45M
Float Shares:48.03M
Volume Ratio:0.93
T/O Rate:3.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1757
EPS(LYR):-1.7400
ROE:-210.35%
ROA:-48.02%
PB:32.98
PE(LYR):-2.39

Loading ...

Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 06, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Dec 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 18, 2024

Correspondence

Form CORRESP - Correspondence
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2024

Major Issues Report

Form 8-K - Current report